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Abstract
Background: Women have a higher risk of lethal arrhythmias than men in long QT syndrome type 2 (LQTS2), but the
mechanisms remain uncertain due to the limited availability of healthy control human tissue. We have previously
reported that in female rabbits, estrogen increases arrhythmia risk in drug-induced LQTS2 by upregulating L-type Ca2+
(ICa,L) and sodium-calcium exchange (INCX) currents at the base of the epicardium by a genomic mechanism. This study
investigates if the effects of estrogen on rabbit ICa,L and INCX apply to human hearts.
Methods: Postmortem human left ventricular tissue samples were probed with selective antibodies for regional
heterogeneities of ion channel protein expression and compared to rabbit myocardium. Functionally, ICa,L and INCX
were measured from female and male cardiomyocytes derived from human induced pluripotent stem cells (iPS-CMs)
with the voltage-clamp technique from control and estrogen-treated iPS-CMs.
Results: In women (n = 12), Cav1.2α (primary subunit of the L-type calcium channel protein 1) and NCX1
(sodium-calcium exchange protein) levels were higher at the base than apex of the epicardium (40 ± 14 and
81 ± 30%, respectively, P < 0.05), but not in men (n = 6) or postmenopausal women (n = 6). Similarly, in
cardiomyocytes derived from female human iPS-CMs, estrogen (1 nM, 1–2 days) increased ICa,L (31%, P < 0.05)
and INCX (7.5-fold, − 90 mV, P < 0.01) and their mRNA levels (P < 0.05). Moreover, in male human iPS-CMs,
estrogen failed to alter ICa,L and INCX.
Conclusions: The results show that estrogen upregulates cardiac ICa,L and INCX in women through genomic
mechanisms that account for sex differences in Ca2+ handling and spatial heterogeneities of repolarization
due to base-apex heterogeneities of Cav1.2α and NCX1. By analogy with rabbit studies, these effects account
for human sex-difference in arrhythmia risk.
Keywords: Sex differences in the human heart, Sex differences in arrhythmia phenotype, 17-β-estradiol,
L-type Ca2+ channel, Sodium-calcium exchanger, Regional heterogeneities in the heart
Background
Sex-dependent arrhythmia risks are particularly pro-
nounced when there is repolarization delay such as in
bradycardia and congenital or drug-induced long QT
syndrome type 2 (LQTS2). Prolongation of the cardiac
action potential (AP) is caused by an imbalance between
the depolarizing and repolarizing ionic currents resulting
in an accompanying prolongation of the QT interval on
the EKG. Congenital long QT type 2 (LQT2) is caused
by mutations of the Kv11.1 K+ channel protein (hERG).
This results in a loss of function of the rapid component
of the delayed rectifying K+ current, IKr, thus prolonging
AP duration (APD) and QT interval [1]. Although the
incidence of all forms of congenital LQT is rare (<1/
5000), drug-induced LQTS remains a particularly serious
public health problem in terms of safety pharmacology
[2–4] because a wide range of cardiac and non-cardiac
drugs suppress IKr, prolong APDs, and promote early
afterdepolarizations (EADs) that lead to potentially lethal
torsade de pointes (TdP) [1, 5–8]. Women are at much
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greater risk than men of experiencing drug-induced
LQTS and developing TdP [9–11].
There is general agreement that torsade de pointes is
initiated by EADs. “Early” EADs that occur early during
the plateau phase of the AP may be caused by the spon-
taneous reactivation of L-type Ca2+ channels [12], whereas
“late” EADs that arise in a later phase of the AP plateau
are caused by an imbalance between the Ca2+ influx and
efflux resulting in sarcoplasmic reticulum (SR) Ca2+ over-
load, spontaneous SR Ca2+ release, and activation of the
forward mode of the Na-Ca exchanger (NCX) current
which can further prolong the AP and trigger EADs by
the reactivation of the L-type Ca2+ current (ICa,L) [13, 14].
A salient feature of LQT2 is the marked sex difference
in arrhythmia risk: women are twice as likely as men to
experience TdP as a result of inherited LQT2 or drug-
induced LQT [11, 15, 16]. These differences disappear in
postmenopausal women over the age of 50 [9, 15, 16]. It
should be noted that postmenopausal women with con-
genital LQT2 have a higher recurrence of syncope, and
these repeated syncope events were not attributed to TdP
[17]. Sex differences in arrhythmia risk have been attrib-
uted to a reduced “repolarization reserve” in adult women,
consistent with their longer rate-corrected QT (QTc) in-
tervals and hence greater susceptibility to IKr blockade
than men [10, 18]. However, the QT interval is not an ac-
curate predictor of arrhythmia risk, with asymptomatic in-
dividuals having long QT and conversely individuals with
QT intervals in the normal range exhibiting severe ar-
rhythmias [19]. A major challenge to unraveling the mo-
lecular mechanisms underlying LQT-related arrhythmias
is the lack of available human myocardial tissues. As a re-
sult, animal models have been extensively used to study
human sex differences, but data are difficult to interpret
due to differences in ion channels expressed in the heart,
different effects of sex steroids, and different propensities
to arrhythmia. In a recent analysis of the data, we pro-
posed that the rabbit may be the best surrogate to study
sex differences in humans [20].
The higher risk of LQT2-related arrhythmias in women
is likewise observed in female New Zealand White rabbits
compared to their male counterparts [21], and the risk is
reversed in both pre-pubertal rabbits [22] and man [23].
In female rabbits, ovariectomy was protective of drug-
induced LQT2-related arrhythmias whereas 17-β-estradiol
replacement reversed the protective effects of ovariectomy
and promoted EADs and arrhythmias [24–26]. These
studies suggest that 17-β-estradiol promotes TdP in
female hearts.
Dual optical mapping of action potentials (APs)
and intracellular free Ca2+ (Cai) transients in a Langen-
dorff rabbit model of drug-induced LQT2 revealed that
adult female hearts were more prone to EADs and TdP
and that the origins of EADs and Cai oscillations preceded
the occurrence EADs [27, 28] [21]. We also showed that
in freshly isolated ventricular myocytes, peak ICa,L density
and Cav1.2α (primary subunit of the L-type Ca2+ channel
protein) channel protein were 25–30% greater at the base
than the apex of adult female compared to male hearts
[21]. Western blot analysis and voltage-clamp studies
showed that the higher level of Cav1.2α at the base of the
adult female heart was associated with a regional elevation
of NCX and INCX [14, 21, 29]. These findings are congru-
ent with data from humans since cardiac contractility is
greater in women than men [30] and myocytes isolated
from women post-transplantation have a tendency to have
greater ICa,L than men [31].
Moreover, incubation of myocytes with 17-β-estradiol
(E2; 1 nM) revealed a regional genomic upregulation of
NCX and Cav1.2α, mRNA, protein levels, and their re-
spective current densities, INCX and ICa,L. These effects are
mediated by estrogen receptors, enhanced transcription
and protein biosynthesis of NCX, and Cav1.2α channel
protein [14, 32]. We extended these studies by showing
that E2 upregulates ICa,L in cultured myocytes isolated
from the base of female hearts by a genomic mechanism
mediated via the α isoform of estrogen receptors (ERα)
but not via the β isoform (ERβ) [32].
Our findings in rabbit hearts [21] were consistent with
a report of endocardium-to-epicardium dispersion of
ICa,L in female but not in male rabbit hearts and with
ICa,L density being higher on the epicardium than the
endocardium and no male-female differences on the
endocardium [33].
These findings raise the question of whether in men
similar mechanisms explain sex differences in
arrhythmia risk in LQTS. Here, we analyzed heteroge-
neities in the expression of ion channels and Ca2
+-transport proteins from the base and apex of the left
ventricular epicardium of healthy human donor hearts.
In addition, the possible role of estrogen-mediated gen-
omic regulation of protein expression was evaluated (a)
indirectly by introducing a third study group of post-
menopausal women who were older than 50 years and
thus expected to have significantly lower levels of estro-
gen than younger adult women and (b) treating female
and male human cardiac myocytes derived from in-
duced pluripotent stem cells with E2 followed by
voltage-clamp measurements of ICa,L and INCX and
their corresponding mRNA levels.
Methods
Human and rabbit tissue samples
Hearts were obtained from organ donors whose non-
diseased hearts were explanted to obtain pulmonary and
aortic valves for transplant surgery. Before cardiac ex-
plantation, organ donors did not receive medication apart
from dobutamine, furosemide, and plasma expanders.
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The investigations conformed to the principles of the
Declaration of Helsinki. The experimental protocols
were approved by the University of Szeged and National
Scientific and Research Ethical Review Boards (No. 51-
57/1997 OEj) and by the Scientific and Research Ethical
Committee of the Medical Scientific Board at the Hun-
garian Ministry of Health (ETT-TUKEB) under ethical
approval No. 4991-0/2010-1018EKU (339/PI/010).
After explantation, each heart was perfused with cardio-
plegic solution and kept cold (4–6 °C) for 2–4 h prior to
dissection. Tissue samples were excised from the subepi-
cardial and subendocardial layers of the left ventricular
base and the subepicardium of the left ventricular apex.
Samples were flash-frozen in liquid nitrogen and stored at
− 80 °C until use. Three groups of myocardial samples
were analyzed: adult men (n = 6), adult women (between
the ages of 17 and 49 years, n = 11), and postmenopausal
women (>50 years, n = 6); the minimum, maximum, and
mean ages for each group are shown by Table 1.
For rabbit cardiac samples, 3-month-old male (n = 2)
and female (n = 3) New Zealand White rabbits were
heparinized (200 U/kg i.v.) and euthanized with an intra-
venous injection of sodium pentobarbital (50 mg/kg).
The hearts were excised and perfused through the aorta
with ice-cold Tyrode’s solution for 5 min, then cardiac
tissue samples were harvested from the base and apex of
the left ventricular epicardium, as previously described
[21]. In previous reports, the base-apex heterogeneities
of Cav1.2α1 and NCX1 (sodium-calcium exchange pro-
tein) on the epicardium were shown to occur in female
but not male adult rabbit hearts [21]. We also reported
spatial heterogeneities along the right ventricle and in-
cluded the spatial heterogeneities of SERCA2a, RyR2,
Nav1.5, and hERG [29]. Here, we probed all the above
channels (see Fig. 2) from the left ventricles of a new set
of male and female adult rabbits.
Protocols were approved by the University of Pitts-
burgh Institutional Animal Care and Use Committee
and were in accordance with the current Guide for the
Care and Use of Laboratory Animals published by the
National Institutes of Health. These studies also comply
with the procurement of the rabbits, and the animal
husbandry and the experiments conform to the
“European Convention for the Protection of Vertebrate
Animals used for Experimental and other Scientific Pur-
poses” (Council of Europe No 123, Strasbourg 1985).
Western blot results were pooled together with earlier
Cav1.2α1 [21, 32] and NCX1 data [14], while, for the
other proteins, earlier samples from 3 female and 3 male
hearts were run in addition to our freshly isolated sam-
ples, reaching a total n number of n = 6 for female and
n = 5 for male rabbits.
Western blots
Cardiac tissue samples were pulverized in liquid nitrogen;
then approximately 100 mg of tissue powder were sus-
pended in lysis buffer containing (in mM) 150 NaCl, 1
EDTA, 2.5 MgCl2, 20 HEPES, 1% Triton X-100, and 0.1%
SDS as well as protease inhibitor cocktail and PMSF (both
from Sigma), then homogenized with a glass-teflon
homogenizer. After 20-min centrifugation at 16,000g, the
supernatants were collected, and the protein concentration
was determined with the Bradford protein assay (Bio-Rad
Laboratories, Hercules, CA, USA). Fifty micrograms of
total protein samples were ran on 4–15% polyacrylamide
gels (Bio-Rad), then transferred to PVDF membranes
(Millipore). After blocking with 5% milk, the membranes
were incubated overnight with primary antibodies against
Cav1.2α1 (rabbit: Santa Cruz sc103588, 1:100; human:
custom antibody from Zymed, 1:250), NCX1 (Thermo Sci-
entific MA3-926, 1:500), SERCA2a (Santa Cruz sc53010,
1:1000), RyR2 (Thermo Scientific MA3-916, 1:500), Nav
1.5 (Alomone Laboratories ASC-005, 1:100), hERG (Santa
Cruz sc15968, 1:100), and GAPDH (glyceraldehyde 3-
phosphate dehydrogenase; Abcam ab70136, 1:1000). After
incubation with alkaline phosphatase conjugated secondary
antibodies (Jackson ImmunoResearch), blots were devel-
oped with the Lumi-Phos reagent (Thermo Scientific), then
imaged and analyzed with the Image Lab GelDoc system
(Bio-Rad). Band intensities were normalized for GAPDH as
a loading control.
In order to immunolabel Cav1.2α1 in human samples,
several antibodies were tested including SC 103588 from
Santa Cruz, ACC-003 from Alomone, and Ab 81980 and
Ab 84814 from Abcam; however, these antibodies did
not give satisfactory results. Therefore, a custom-made
antibody produced by Zymed was used, which gave a
single band around 250 kDa, and this band disappeared
when the antibody was pre-incubated with the immuno-
gen peptide.
Protein expression was compared for the three groups
(4 men, 6 adult females, and 4 postmenopausal females)
between the base and apex of the left ventricular epicar-
dium, the epi, and the endocardium of the left ventricu-
lar base. Left ventricular samples from the base of the
three groups were run on the same gel.
iPS-CM cell culture
Commercially available human male and female iPSC-
derived cardiac myocytes (iPS-CMs, Axol Bioscience,
UK) were prepared according to the manufacturer’s
Table 1 Summary of the number of individuals (n) and ages of
the human used in the study
Group Men
(n = 6)
Adult women
(n = 11)
Postmenopausal
women (n = 6)
Mean age (years) 45 34 56
Min-Max (years) 32–58 17–49 51–68
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instructions. Briefly, cardiac myocytes (1 ml, stored fro-
zen in liquid N2) thawed in a 37 °C water bath were ini-
tially suspended in 1 ml Axol Complete Cardiomyocyte
Medium (warmed to 37 °C). An additional 8 ml of
medium was added and mixed by gentle inversion. Car-
diac myocytes were seeded (25,000 cells/well) in 1.5 ml
medium in 12 well culture plates that contained glass
coverslips (15-mm diameter, Warner Instruments, CT)
pre-coated with Matrigel™ (Corning Life Sciences, MA).
Cells were incubated for 24 h at 37 °C, 7% CO2. Non-
adherent cells were removed by rinsing with media.
After 7 days in culture, 17-β-estradiol (Sigma) was added
to the media at a final concentration of 1 nM. The iPS-
CMs were kept in 17-β-estradiol for 24–48 h before
measuring ICa,L or INCX by voltage-clamp technique.
Control cells were treated with media containing DMSO
(< 0.1%). Cultured iPS-CMs had a tendency to mature
and exhibit spontaneous contractions by the 7th day of
incubation. The male and female iPS-CMs used in this
study had common features found in all iPS-CMs: spon-
taneous automaticity and contractions and stable ionic
currents for weeks, as previously reported [34].
Electrophysiology
Electrophysiological measurements were performed in
the whole-cell voltage-clamp configuration. Glass re-
cording electrodes with resistances of 1–1.5 MΩ were
pulled from borosilicate glass (T1W150-4. World Preci-
sion Instruments, FL) using a Sutter micropipette puller.
For recording ICa,L, pipettes were filled with (in mM):
Table 2 Nucleotide sequence of primers used
GAPDH-F 5'-AAT TGA GCC CGC AGC CTC CC-3'
GAPDH-R 5'-GAG CGA TGT GGC TCG GCT GG-3'
Troponin-F 5'-CAA GCA GGT GAA GAA GGA GG-3'
Troponin-R 5'-CAG TAG GCA GGA AGG CTC AG-3'
Cav1.2α-R 5'-GCC TAC CTC CGC AAC GGC TG-3'
Cav1.2α-F 5'-CGG CCC CTT TCC CTC CGA GA-3'
NCX-F 5'-ACC TGT TTG GCC AAC CTG TCT TCA-3'
NCX-R 5'-TGC TGG TCA GTG GCT GCT TGT-3
a
b
Fig. 1 Comparison of protein expression between the base (B) and apex (A) of the left ventricular epicardium in humans. Protein samples from
the base (B) and the apex (A) of the LV epicardium were obtained from 3 men, 3 women, and 3 postmenopausal women and were probed with
antibodies to compare the relative expression of Cav1.2α, NCX1, SERCA2a, RyR2, Nav1.5, and hERG. Panel a shows the protein densities which
were normalized with respect to GAPDH. Panel b is a histogram of normalized band intensities expressed as base-apex percent differences
derived from an analysis of myocardium from 6 men, 11 women, and 6 postmenopausal women
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115 CsCl, 20 TEA-Cl, 1 MgSO4, 5 EGTA, 5 MgATP, 5
Tris-creatine PO4, 0.3 Tris-GTP, and 10 HEPES
(pH 7.2). The external solution contained (in mM): 144
NMDG-Cl, 12 CsCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and
10 glucose (pH 7.35). Cells were clamped at − 80 mV
with currents recorded over a 500-ms voltage step from
the holding potential to potentials between − 110 and
70 mV in increments of 10 mV. For recording INCX, pi-
pettes were filled with (in mM): 120 glutamic acid, 120
CsOH, 0.5 MgSO4, 20 NaCl, 10 EGTA, 3 CaCl2, 5
MgATP, and 10 HEPES (pH 7.2). The external solution
contained (in mM): 140 NaCl, 10 CsCl2, 1 CaCl2, 1
MgCl2, 10 HEPES, and 10 glucose (pH 7.4). Nifedipine
(10 μM) and ouabain (10 μM) were added to the exter-
nal solution to inhibit Ica,L and the Na-K ATPase, re-
spectively. Cells were clamped at − 50 mV and then
stepped to + 100 mV for 80 ms followed by a descending
voltage ramp from + 100 to − 120 mV over 1600 ms.
INCX was determined by measuring the Ni
2+-sensitive
current in the voltage ramp. The residual currents mea-
sured in the presence of 5 mM Ni2+ were subtracted
from the total current recorded in the absence of Ni2+.
All measured currents were normalized to the cell
capacitance.
qRT-PCR
On days 2, 3, and 4 after initial treatment with beta-
estradiol, RNA was isolated from treated and vehicle
(DMSO) control wells using a RNeasy Micro Kit (Qia-
gen) according to the manufacturer’s instruction. cDNA
was prepared from the isolated RNA (1 μg) using a
QuantiTect Reverse Transcription kit (Qiagen). Table 2
shows the nucleotide sequence of the primers used in
the study. Quantitative real-time PCR (qPCR) was per-
formed using the iQ SYBR Green Supermix (Bio-Rad).
Samples were amplified in triplicate. Amplifications were
performed using the MyIQ Real-time PCR detection sys-
tem (Bio-Rad). Conditions were as follows: 50 °C for
2 min, 1 cycle; 95 °C for 3 min, 1 cycle; 95 °C for 15 s ➔
60 °C for 1 min, 40 cycles; followed by a melting curve
analysis: 55–95 °C in 0.5 °C increments for 2 s a step.
Data was analyzed using IQ 5 Optical System Software
(Bio-Rad), and Excel using the ΔΔCt method.
Statistical analysis
Data are shown as mean ± SEM of the percentage differ-
ences between the base and apex or between the epicar-
dium and endocardium, respectively. Base vs apex and
epicardial vs endocardial protein levels were compared
with the paired t test, and differences were considered
significant at P ≤ 0.05. Patch clamp data are shown as
mean ± SEM normalized to cell capacitance. Results
were compared with the unpaired t test and were con-
sidered significant at P ≤ 0.05.
Results
From left ventricular epicardial tissue samples, we found
that adult women (n = 11), but not men (n = 6) or post-
menopausal women (n = 6), had a higher expression of
Cav1.2α1 and NCX1 (40 ± 14 and 81 ± 30%, respectively,
P < 0.05) at the base compared to the apex (Fig. 1a, b).
These regional differences were similar to those found in
female rabbits (106 ± 50 and 185 ± 53%, respectively) (Fig.
2). In women, SERCA2a was also more abundant at the
base compared to the apex (130 ± 67%), and this large
spatial gradient was not observed in men or postmeno-
pausal women. In contrast, female rabbits did not have a
difference in SERCA2 expression, but male rabbit hearts
had significantly higher expression of SERCA2a at the
base than apex (Fig. 2). On the other hand, Nav1.5 protein
expression, which exhibited a base-apex difference in fe-
male rabbits, was homogeneous throughout the epicar-
dium in all human groups. No significant differences in
the expression of RyR2 occurred in any group, in any spe-
cies. In rabbits, the expression of rERG was higher at the
apex in both sexes. In contrast, hERG expression in
humans had a similar tendency (statistically not signifi-
cant) in women (Fig. 1), whereas, in men and postmeno-
pausal women, hERG had a tendency to be more
a
b
Fig. 2 a Western blots of base-apex differences in channel protein
expression in male and female rabbit left ventricular epicardium. b
Base-apex percent differences in protein expression on the rabbit left
ventricular epicardium
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abundant at the base. Table 3 summarizes the distribution
of key ion channel proteins in human myocardium and
calculations regarding their base-apex differences.
Cav1.2α and NCX1 showed a tendency to be more
abundant on the epicardium compared to the endocar-
dium, but these differences did not reach statistical sig-
nificance in any of the groups (Fig. 3). SERCA2a was
significantly higher on the epicardium compared to the
endocardium, but this effect was not sex-related since it
occurred in all the three human study groups (men
197 ± 69%, adult women 131 ± 39%, postmenopausal
women 190 ± 105%). Nav1.5 showed a tendency to be
more abundant on the endocardium, but did not reach
statistical significance except in postmenopausal women.
hERG had a tendency of higher levels on the endocar-
dium that did not reach statistical significance.
Effects of E2 on human iPS-CMs
Female cardiomyocytes derived from induced pluripotent
stem cells (iPS-CM) were cultured with 1 nM 17-β-
estradiol (E2) or vehicle (control) for 1–3 days; then ICa,L
density was recorded as a function of membrane potential
(Vm). E2-treated myocytes had a significantly higher peak
current compared to vehicle-treated iPS-CMs (from −
4.64 ± 0.35 (n = 15) to − 6.09 ± 0.55 pA/pF; n = 13, at
0 mV, P < 0.05) (Fig. 4a). Similarly, the Ni2+-sensitive Na-
Ca exchange current, INCX, was significantly larger in iPS-
CMs treated with E2 (1 nM) compared to myocytes treated
with vehicle (Fig. 4b. At − 90 mV, INCX current density in
iPS-CMs incubated with E2 was − 2.20 ± 0.54 pA/pF
(n = 5) compared to − 0.29 ± 0.13 pA/pF (n = 5, P < 0.01).
The increases in ICa,L and INCX densities were accompan-
ied with higher levels of mRNA for Cav1.2α (2.93 ± 0.57-
fold increase, n = 10, P < 0.05) and for NCX1 (3.24 ± 1.22-
fold increase, n = 9, P < 0.05) relative to glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), as a housekeeping
gene.
Male human iPS-CMs treated with 17-β-estradiol
showed a trend for increased peak current density at −
10 mV as compared to vehicle-treated iPS-CMs (17-β-
estradiol-treated − 4.49 ± 0.50 pA/pF, n = 5 vs. vehicle-
treated − 3.19 ± 0.88, n = 5, NS at P < 0.05) (Fig. 5a).
There was no effect of 17-β-estradiol on INCX in male
myocytes as compared to vehicle (Fig. 5b).
Discussion
Our earlier findings in female rabbits linked the initiation
of EADs and TdP to regions at the base of the ventricles
where there was higher expression of Cav1.2α1 and
NCX1, their mRNA and their respective currents ICa,L
and INCX. Here, we analyzed the density of ion channel
proteins in left ventricles from healthy human donor
hearts and found that adult women, similar to female rab-
bits, have significantly higher levels of Cav1.2α1 and
NCX1 at the base of the epicardium compared to the
apex. This difference was sex- and age-dependent as it did
Table 3 Distribution of key ion channel proteins in human myocardium and calculations regarding base-apex differences
Protein Group Base Apex % Difference P value
Cav1.2α Men 0.49 ± 0.1 0.47 ± 0.1 4.1% 1.0000
Adult women 0.57 ± 0.12 0.38 ± 0.09 48.8%* 0.0002
Postm. women 0.74 ± 0.25 0.59 ± 0.17 24.1% 0.5625
NCX1 Men 0.71 ± 0.07 0.64 ± 0.13 10.9% 0.6875
Adult women 0.68 ± 0.18 0.41 ± 0.12 67.4%* 0.0024
Postm. women 0.67 ± 0.1 0.63 ± 0.15 6% 0.8438
SERCA2a Men 2.67 ± 1.19 1.76 ± 0.37 52.2% 1.0000
Adult women 2.43 ± 0.59 1.44 ± 0.33 68.7%* 0.0398
Postm. women 0.94 ± 0.23 0.99 ± 0.28 −5.8% 0.5625
RyR2 Men 0.95 ± 0.28 0.94 ± 0.14 0.5% 1.0000
Adult women 0.41 ± 0.11 0.5 ± 0.11 −17.3% 0.3804
Postm. women 0.26 ± 0.09 0.22 ± 0.04 17.6% 0.6875
Nav1.5 Men 1.96 ± 0.35 1.97 ± 0.33 −0.8% 1.0000
Adult women 1.16 ± 0.2 1.18 ± 0.28 −1.8% 0.8394
Postm. women 1.03 ± 0.13 1.21 ± 0.19 −15% 0.2188
hERG Men 0.19 ± 0.09 0.09 ± 0.03 97% 0.6250
Adult women 0.17 ± 0.08 0.46 ± 0.24 −63.4% 0.1230
Postm. women 0.35 ± 0.15 0.24 ± 0.09 47.8% 0.1250
Group mean ± SEM density values for each protein, normalized with GAPDH, and % base-apex differences in the human left ventricular epicardium. * P < 0.05,
Wilcoxon matched-pairs signed rank test.
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not occur in adult men or in postmenopausal women sup-
porting the interpretation that estrogen regulates the ex-
pression of these proteins. Moreover, female human
cardiomyocytes derived from induced pluripotent stem
cells responded to estrogen (1 nM) in the culture medium
by a genomic upregulation (in 1–2 days) of mRNA levels
and current densities of ICa,L and INCX.
In female rabbit hearts, we recently showed that the
higher expression of Cav1.2α and NCX1 produce aberrant
systolic Ca2+ handling that trigger EADs and arrhythmias
under conditions of repolarization delay, namely bradycar-
dia [29] and drug-induced long QT [35]. Although the link
between repolarization delay, Ca2+ overload, and arrhyth-
mias was demonstrated in rabbit hearts, the same mechan-
ism most likely applies to human hearts because sex
differences in arrhythmia risk in rabbits closely match the
profile of human arrhythmias associated with repolarization
delays [20]. The base-apex heterogeneities of cellular Ca2+
handling are a result of an upregulation of ICa,L and INCX
by 17-β-estradiol at myocytes isolated from the base of the
ventricles [14, 21, 32]. The higher density of ICa,L and INCX
is mediated by estrogen receptors (α and β isoforms: ERα
and ERβ), requires 24–48 h, and was inhibited by blockers
of transcription or translation; hence, estrogen acts via a
genomic mechanism [14, 32]. Agonists of both ERα and
ERβ upregulate NCX1, whereas only agonists of ERα up-
regulate Cav1.2α. Moreover, in silico analysis of the pro-
moter region of human and rabbit CACNA1C detected 8
high-probability estrogen receptor ERα (but not ERβ) bind-
ing sites within the first 500 nucleotides of the promoter re-
gion (at http://genome.ucsc.edu and BIOBASE Knowledge
Library). Chip-on-chip analysis of the human CACNA1C
detected the same 8 high-quality ERα binding sites in the
promoter region in human MCF-7 cells [36]. The analysis
suggests that estrogen regulates the transcription of the
gene that encodes for Cav1.2α in human and rabbit hearts
via ERα (but not ERβ) by a “classical” genomic mechanism.
Consistent with bioinformatics findings, we now show that
estrogen upregulates ICa,L in isolated human iPS-derived
cardiomyocytes.
An interesting unresolved question is why myocytes
from the base respond to estrogen treatment but myocytes
a
b
Fig. 3 Comparison of protein expression between the epicardium (Ep) and endocardium (En) of the left ventricular myocardium in human hearts.
Protein samples from the epicardium (Ep) and endocardium (En) of the LV were obtained from 3 men, 3 women, and 3 postmenopausal women
and were probed with antibodies to compare the relative expression of Cav1.2α, NCX1, SERCA2a, RyR2, Nav1.5, and hERG. Panel a shows the
protein densities which were normalized with respect to GAPDH. Panel b is a histogram of normalized band intensities expressed as epi-endo
percent differences derived from an analysis of myocardium from 6 men, 11 women, and 6 postmenopausal women
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from the apex do not. A possible mechanism could be dif-
ferences in the expression of receptor ERα and ERβ be-
tween the apex and base. However, we showed by Western
blot analysis that both receptors are equally expressed at
the base and apex of ventricles in both male and female
myocardium [32]. A promising alternative mechanism to
explain base-apex differences in the response to estrogen
is to analyze base-apex differences in the activation of
transcription factors from the same hearts, an approach
that is only applicable to animal models.
Besides base-apex differences on the epicardium, we
also examined epicardium-to-endocardium differences.
In rabbit hearts, endocardial cells from the base did not
respond to estrogen [14] and both Cav1.2α and NCX1
showed a tendency to be higher on the epicardium than
the endocardium confirming an earlier study of higher
expression of Cav1.2α on the female rabbit epicardium
[37]. Transmural dispersion of repolarization measured
with plunge electrodes was greater in female than male
rabbits and contributed to the higher incidence of tor-
sade de pointes in female hearts [38].
In dog hearts, INCX and ICa,L densities were greater on
the epicardium than endocardium [39] and the
sarcoplasmic reticulum (SR) Ca2+ load was higher in the
epicardium. The higher INCX and SR load is consistent
with the higher SERCA2a levels on the epicardium of
human hearts, which was found in non-failing and fail-
ing hearts [40] and in normal male and female hearts
(Fig. 3). Nav1.5 was found to be higher on the endocar-
dium by Gaborit et al. [41], and we show a similar ten-
dency irrespective of sex.
The higher expression of Cav1.2α at the base vs apex
is observed in women and in rabbits and so are increases
in NCX1. One might speculate that the higher influx of
Ca2+ occurring through ICa,L is somewhat balanced by
the higher Ca2+ efflux through INCX. While there are sex
differences in Ca2+ handling across the plasma mem-
brane, little is known regarding sex differences in Ca2+
transport across the sarcoplasmic reticulum. In women,
SERCA2a was more abundant at the base compared to
the apex, and this large spatial gradient was not ob-
served in men or postmenopausal women; in contrast,
there were no spatial gradients of RyR2 in all three
groups. The gradient of SERCA2a seen in women was
not observed in female but was striking in male rabbit
hearts (Fig. 2). Further studies will be needed to
Fig. 4 Effect of E2 incubation on ICa,L and INCX of female human iPS-CMs. a ICa,L current-voltage relationship from cardiac myocytes derived from
hiPS cells was measured in cells cultured with 1 nM E2 (filled circles, n = 13) and compared to those cultured with vehicle (empty circles, n = 15).
ICa,L was significantly increased by E2 incubation. (*P < 0.05). b INCX was measured as a function of voltage in female human iPS-CMs that were
incubated with estradiol (filled circles, n = 5) and compared to iPS-CMs incubated with the vehicle (control) (empty circles, n = 5). There was a
significant increase in INCX when incubated with E2. *P < 0.05
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determine the functional consequences of these regional
sex differences in SERCA2a in terms of the amplitude
and rate of SR Ca2+ uptake and whether these differ-
ences are modulated by sex hormones.
Limitations of availability and viability in culture of
healthy human ventricular myocytes precluded studying
the estrogen response of isolated myocytes from the base
and apex of normal human hearts under voltage clamp.
Instead, we tested human iPS-CMs which are known to
retain many features of adult ventricular myocytes [34].
As shown here, estrogen-treated female human iPS-CMs
exhibited a genomic upregulation of Cav1.2α1 and
NCX1 akin to cells from the base of the heart, even
though heterogeneity of iPS-CMs may obscure larger
changes associated with regional differences of the heart.
At physiological membrane potentials (+ 10 to −
90 mV), INCX was considerably greater in male than in
female human iPS-CMs (for instance, INCX = 0.19 pA/pF
in females and − 1.2 mV in males; at − 80 mV). Incuba-
tion with estrogen tended to reduce INCX in male and
significantly increased INCX in female iPS-CMs. The en-
dogenously greater INCX in males could be due to a
number of factors involving iPS-CM maturation and
intracellular ionic concentrations.
Unfortunately, sex hormone levels of the organ donors
are unknown, and we can only surmise that the donors
had normal physiological levels. Nevertheless, the myo-
cardium of young adult females exhibited regional differ-
ences in the expression of Cav1.2α1 and NCX1, a profile
that was absent in men and in postmenopausal women.
The lack of regional differences in ion channel and
calcium-handling protein expression in postmenopausal
hearts (reduced estrogen levels) also serves as corrobor-
ating evidence that the heterogeneities observed in
young adult women are due to genomic regulation by
estrogen, similar to findings in female rabbits.
There is an extensive literature focused on the effects of
sex steroids on K+ channels and QT intervals and related
to sex differences in arrhythmia risk. But most studies have
rarely paid attention to regional (base-apex) differences in
ion channel distribution, calcium-handling mechanisms, or
genomic regulation [41]. Studies on repolarizing K+ cur-
rents explain differences in action potential duration but
not the initiation of EADs which trigger TdP. Indeed, the
formation of EADs has been shown to result from cellular
elevation of Ca2+ that activates INCX (forward mode) and
elicits the reactivation of ICa,L. Our study is the first to dem-
onstrate that base-apex differences on the epicardium of
the human heart are sex-dependent and occur only in adult
women and that these differences trump transmural het-
erogeneities, which, if they occur, do not seem to be sex-
related. Therefore, the higher incidence of drug-induced
TdP in women and in female animals could rather be ex-
plained by a base-apex heterogeneity of ion channel and
calcium-handling protein expression on the epicardium.
Conclusions
It has long been assumed that sex differences in arrhythmia
risk in cases of repolarization delay (e.g., bradycardia and
long QT) was due to a “reduced repolarization reserve,”
(e.g., a suppression of repolarizing K+ currents) in female
hearts. However, optical mapping revealed that in rabbit
hearts, these arrhythmias were initiated by abnormalities in
Ca2+ handling. Further studies showed that estrogen
imparted these sex differences in adult females through a
genomic upregulation of the L-type Ca2+ channel and the
Na+-Ca2+ exchanger. These findings altered the mecha-
nisms of action of class III anti-arrhythmic agents and
Fig. 5 Effect of E2 incubation on ICa,L and INCX of male human iPS-CMs.
a Effect of 17-β-estradiol on ICa,L in male iPS-CMs. ICa,L was measured as
described in the methods in male iPS-CMs following treatment with
17-β-estradiol (filled circles) and vehicle (empty circles). 17-β-estradiol
treatment displayed a small but not significant increase in ICa,L as
compared to vehicle treatment. b Effect of 17-β-estradiol on INCX in
male iPS-CMs. Shown are the averaged current density for INCX
obtained from male iPS-CMs treated with 17-β-estradiol (filled circles)
and vehicle (empty circles)
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shifted to Ca2+ overload as a target to suppress torsade de
pointes. The central goal of this study is to examine the hu-
man relevance of findings obtained in rabbit hearts. In
principle, equivalent experiments would require tissue and
cell isolation from different regions of healthy human
hearts to measure the genomic effects of estrogen. Instead,
we used postmortem myocardium from healthy hearts to
analyze sex differences in ion channel expression and hu-
man cardiomyocytes derived from induced pluripotent
stem cells to measure the functional effects of estrogen on
Ca2+ currents. The data shows that there is a close corres-
pondence between rabbit and human myocyte responses to
estrogen at very low estrogen concentrations. These gen-
omic effects of estrogen at 1 nM trump the acute effects of
estrogen on ionic currents observed at micromolar concen-
trations. Hence, the higher risk of women to torsade de
pointes may be caused by a greater Ca2+ overload in condi-
tions of repolarization delays. Estrogen binding to estrogen
receptor α may act as a transcription factor to upregulate
channel expression and promote Ca2+ overload. From a
public health point of view, the study suggests that Ca2
+-handling proteins may be important targets to suppress
torsade de pointes.
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